Who invested in Oxford Endovascular

3 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$21Mraised across 3 rounds since 2021, from 3 sources

$238KRound$10MRound$10MSeries A

Latest round: Series A, $10MMay 2024
Investors: 5

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

202220232024

$238KRound$10MRound$10MSeries A

First round: Round, $238K
Biggest round: $10M
Usual gap between rounds: 2.6 years

The rounds

May 2024
Series A$10M5 new
Source recorded
Jan 2024
Round$10M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Jul 2021
Round$238K
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Round2021Round2024Series A2024

Innovate UKEISMEA

Parkwalk

Oxford Science Enterprises

EASME - EU Executive Agency for SMEs

Everyone who backed them

Innovate UKVC firm1round

EISMEAInvestment firm1round

ParkwalkVC firm1round

Oxford Science EnterprisesVC firm1round

EASME - EU Executive Agency for SMEsGovernment1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Oxford Endovascular as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.